Entropy Technologies, LP Intra Cellular Therapies, Inc. Put Options Transaction History
Entropy Technologies, LP
- $952 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
377Shares Held
84.1MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$810 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$532 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$445 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$324 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$257 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.94B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...